安井博史 (Hirofumi Yasui) - マイポータル

基本情報

J-GLOBAL ID: 201801014497879670
researchmap会員ID: B000310077

研究分野

その他 / その他 /

論文

ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

Akihito Kawazoe, Kensei Yamaguchi, Tetsuya Hamaguchi, Yukiya Narita, Shogen Boku, Takashi Oshima, Hiroki Hara, Yasuo Hamamoto, Kenji Ishido, Taito Esaki …

Cancer science 116(9) 2523-2536 2025年9月
Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, non-comparative trial.

Hirotoshi Ishiwatari, Kazuma Ishikawa, Junya Sato, Fumitaka Niiya, Hirofumi Yasui, Yusuke Onozawa, Kentaro Yamazaki, Akiko Todaka, Takahiro Tsushima, Satoshi Hamauchi …

Gastrointestinal endoscopy 2025年6月28日
Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Satoshi Suzuki, Tomoya Yokota, Akifumi Notsu, Satoshi Hamauchi, Kunihiro Fushiki, Kotoe Oshima, Akihiro Ohba, Takeshi Kawakami, Takahiro Tsushima, Hirofumi Yasui …

International journal of clinical oncology 2025年6月25日
Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.

Satoshi Suzuki, Tomoya Yokota, Akifumi Notsu, Satoshi Hamauchi, Yusuke Onozawa, Kunihiro Fushiki, Kotoe Oshima, Takeshi Kawakami, Takahiro Tsushima, Hirofumi Yasui …

The oncologist 29(10) e1315-e1323 2024年10月3日
Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia.

Ari Nishimura, Satoshi Hamauchi, Akifumi Notsu, Kunihiro Fushiki, Kotoe Oshima, Takahiro Tsushima, Takeshi Kawakami, Akiko Todaka, Tomoya Yokota, Hirofumi Yasui …

BMC palliative care 23(1) 214-214 2024年8月24日
Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients.

Hiroyuki Matsubayashi, Akiko Todaka, Takeshi Kawakami, Satoshi Hamauchi, Tomoya Yokota, Satomi Higashigawa, Yoshimi Kiyozumi, Rina Harada, Nobuhiro Kado, Seiichiro Nishimura …

Journal of human genetics 68(2) 81-86 2023年2月
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin.

Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui, Kentaro Yamazaki

BMC cancer 23(1) 68-68 2023年1月20日
Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study.

Sae Ohwada, Akiko Todaka, Hiroshi Nakase, Hiromichi Shirasu, Takeshi Kawakami, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui …

Investigational new drugs 40(5) 1106-1116 2022年10月
Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.

Satomi Higashigawa, Hiroyuki Matsubayashi, Yoshimi Kiyozumi, Nobuhiro Kado, Seiichiro Nishimura, Takuma Oishi, Takashi Sugino, Kunihiro Fushiki, Hiromichi Shirasu, Hirofumi Yasui …

Japanese journal of clinical oncology 52(6) 599-608 2022年4月12日
Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses.

Hiroyuki Matsubayashi, Satomi Higashigawa, Yoshimi Kiyozumi, Takuma Oishi, Keiko Sasaki, Hirotoshi Ishiwatari, Kenichiro Imai, Kinichi Hotta, Yohei Yabuuchi, Kazuma Ishikawa …

BMC cancer 22(1) 73-73 2022年1月17日
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis.

Masaki Takinami, Akira Ono, Takanori Kawabata, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami …

Investigational new drugs 39(6) 1716-1723 2021年12月
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis

Sadayuki Kawai, Nozomi Takeshima, Yu Hayasaka, Akifumi Notsu, Mutsumi Yamazaki, Takanori Kawabata, Kentaro Yamazaki, Keita Mori, Hirofumi Yasui

BMC Cancer 21(1) 2021年12月
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07).

Taroh Satoh, Ken Kato, Takashi Ura, Yasuo Hamamoto, Takashi Kojima, Takahiro Tsushima, Shuichi Hironaka, Hiroki Hara, Satoru Iwasa, Kei Muro …

Esophagus : official journal of the Japan Esophageal Society 18(4) 835-843 2021年10月査読有り
Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck

Ari Nishimura, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Hiromichi Shirasu, Takanori Kawabata, Hirofumi Ogawa, Tsuyoshi Onoe, Yoshiyuki Iida, Takashi Mukaigawa …

International Journal of Clinical Oncology 2021年6月21日査読有り
Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.

Ryoma Haneda, Eisuke Booka, Kenjiro Ishii, Hirotoshi Kikuchi, Yoshihiro Hiramatsu, Kinji Kamiya, Hirofumi Ogawa, Hirofumi Yasui, Hiroya Takeuchi, Yasuhiro Tsubosa

World journal of surgery 45(6) 1835-1844 2021年6月
Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer.

Kensei Yamaguchi, Nozomu Fuse, Yoshito Komatsu, Hirofumi Fujii, Shuichi Hironaka, Yasushi Omuro, Kei Muro, Hirofumi Yasui, Shinya Ueda, Tomohiro Nishina …

Japanese journal of clinical oncology 51(6) 879-885 2021年5月28日
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer.

Hiroto Inoue, Akiko Todaka, Kentaro Yamazaki, Kunihiro Fushiki, Hiromichi Shirasu, Takeshi Kawakami, Takahiro Tsushima, Satoshi Hamauchi, Tomoya Yokota, Nozomu Machida …

Investigational new drugs 39(5) 1399-1404 2021年4月9日
The Negative Impact of Preoperative Chemotherapy on Survival After Esophagectomy for Vulnerable Elderly Patients with Esophageal Cancer.

Eisuke Booka, Ryoma Haneda, Kenjiro Ishii, Takahiro Tsushima, Hirofumi Yasui, Yasuhiro Tsubosa

Annals of surgical oncology 28(3) 1786-1795 2021年3月
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.

Hiroyuki Arai, Masahiro Kawahira, Hirofumi Yasui, Toshiki Masuishi, Kei Muro, Takako Eguchi Nakajima

International journal of clinical oncology 26(2) 355-363 2021年2月査読有り
Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study.

Hirotsugu Kenmotsu, Akifumi Notsu, Keita Mori, Shota Omori, Takahiro Tsushima, Yasuomi Satake, Yoshihiro Miki, Masakazu Abe, Masahito Ogiku, Toshio Nakamura …

Cancer medicine 2021年1月9日

もっとみる

MISC

Phase II study of S-1 plus oxaliplatin 130 mg/m2 in Japanese patients with advanced gastric cancer.

Yosuke Kito, Nozomu Machida, Sadayuki Kawai, Satoshi Hamauchi, Takahiro Tsushima, Akiko Todaka, Tomoya Yokota, Kentaro Yamazaki, Akira Fukutomi, Yusuke Onozawa …

International journal of clinical oncology 23(6) 1084-1089 2018年12月
Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.

Takeshi Kawakami, Takahiro Tsushima, Katsuhiro Omae, Hirofumi Ogawa, Hiromichi Shirasu, Yosuke Kito, Yukio Yoshida, Satoshi Hamauchi, Akiko Todaka, Nozomu Machida …

BMC cancer 18(1) 573-573 2018年5月18日
Predictive value of tumor growth rate during previous treatment for tumor response to regorafenib (REGO) and trifluridine/tipiracil (TFTD) in metastatic colorectal cancer (mCRC).

Takeshi Kawakami, Toshiki Masuishi, Yasuyuki Kawamoto, Katsuhiro Omae, Tetsuhito Muranaka, Hiroshi Nakatsumi, Satoshi Yuki, Yoshito Komatsu, Kentaro Yamazaki, Yusuke Onozawa …

JOURNAL OF CLINICAL ONCOLOGY 36(4) 2018年2月
Safety and efficacy of chemoradiotherapy for high risk stage II laryngeal cancer

Satoshi Hamauchi, Tomoya Yokota, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Tomoyuki Kamijo, Yoshiyuki Iida, Tetsuo Nishimura, Tetsuro Onitsuka, Hirofumi Yasui

ANNALS OF ONCOLOGY 28 2017年10月
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.

Toshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi, Azusa Komori, Yosuke Kito, Yukiya Narita, Takahiro Tsushima, Makoto Ishihara, Akiko Todaka, Tsutomu Tanaka …

Clinical colorectal cancer 16(2) e15-e22 2017年6月
Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102.

Satoshi Hamauchi, Kentaro Yamazaki, Toshiki Masuishi, Yosuke Kito, Azusa Komori, Takahiro Tsushima, Yukiya Narita, Akiko Todaka, Makoto Ishihara, Tomoya Yokota …

Clinical colorectal cancer 16(1) 51-57 2017年3月
Efficacy of bevacizumab in combination with doublet chemotherapy as first-line therapy in metastatic colorectal cancer according to KRAS status.

Katsuyuki Murai, Toshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi, Keiji Sugiyama, Takahiro Tsushima, Seiichiro Mitani, Akiko Todaka, Kazunori Honda, Tomoya Yokota …

JOURNAL OF CLINICAL ONCOLOGY 35(4) 2017年2月
Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

Sadayuki Kawai, Tomoya Yokota, Yusuke Onozawa, Satoshi Hamauchi, Akira Fukutomi, Hirofumi Ogawa, Tsuyoshi Onoe, Tetsuro Onitsuka, Takashi Yurikusa, Akiko Todaka …

BMC cancer 17(1) 59-59 2017年1月17日
Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer.

Takeshi Kawakami, Nozomu Machida, Hirofumi Yasui, Masahiro Kawahira, Sadayuki Kawai, Yosuke Kito, Yukio Yoshida, Satoshi Hamauchi, Takahiro Tsushima, Akiko Todaka …

Cancer chemotherapy and pharmacology 78(4) 809-14 2016年10月
TAS-102 in patients with metastatic colorectal cancer refractory to standard therapies including regorafenib

Yosuke Kito, Satoshi Hamauchi, Kentaro Yamazaki, Azusa Komori, Toshiki Masuishi, Hiroya Taniguchi, Keita Mori, Kei Muro, Hirofumi Yasui

ANNALS OF ONCOLOGY 27 2016年7月
Metastatic colorectal cancer patients who achieved long progression-free survival by regorafenib or TAS-102 therapy

Yosuke Kito, Satoshi Hamauchi, Kentaro Yamazaki, Azusa Komori, Toshiki Masuishi, Hiroya Taniguchi, Keita Mori, Kei Muro, Hirofumi Yasui

ANNALS OF ONCOLOGY 27 2016年7月
Phase II study of nivolumab (ONO-4538/BMS-936558) in patients with esophageal cancer: Preliminary report of overall survival.

Takashi Kojima, Hiroki Hara, Kensei Yamaguchi, Shuichi Hironaka, Satoru Iwasa, Ken Kato, Takahiro Tsushima, Hirofumi Yasui, Takashi Ura, Kei Muro …

JOURNAL OF CLINICAL ONCOLOGY 34(4) 2016年2月
A retrospective comparison between regorafenib and TAS-102 for refractory metastatic colorectal cancer.

Toshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi, Azusa Komori, Yosuke Kito, Seiichiro Mitani, Hiroko Hasegawa, Yukiya Narita, Shigenori Kadowaki, Takashi Ura …

JOURNAL OF CLINICAL ONCOLOGY 34(4) 2016年2月
Establishment and validation of prognostic nomograms including HER2 status in metastatic gastric cancer

Takeshi Kawakami, Yukiya Narita, Isao Oze, Shigenori Kadowaki, Nozomu Machida, Hiroya Taniguchi, Takashi Ura, Masashi Ando, Seiji Ito, Yasushi Yatabe …

JOURNAL OF CLINICAL ONCOLOGY 34(4) 2016年2月
Exploratory analysis of prognostic subset in esophageal cancer patients previously treated with FU, Pt, taxane therapy

Motoo Nomura, Satoru Iwasa, Takahiro Tsushima, Ken Kato, Hirofumi Yasui, Kei Muro, Narikazu Boku

ANNALS OF ONCOLOGY 26 115-115 2015年11月
Re-introduction of taxane for patients with esophageal squamous cell carcinoma refractory to 5-FU, CDDP, and a taxane

Takahiro Tsushima, Nomura Motoo, Satoru Iwasa, Ken Kato, Hirofumi Yasui, Kei Muro, Narikazu Boku

ANNALS OF ONCOLOGY 26 115-115 2015年11月
Concurrent CBDCA plus radiotherapy for locally advanced head and neck cancer patients inappropriate for use of CDDP

Satoshi Hamauchi, Tomoya Yokota, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Tetsuo Nishimura, Tomoyuki Kamijo, Yoshiyuki Iida, Tetsuro Onitsuka, Hirofumi Yasui

ANNALS OF ONCOLOGY 26 135-135 2015年11月
Multidisciplinary treatment in patients with leptomeningeal metastasis from gastric cancer

Koichi Mitsuya, Nakamasa Hayashi, Satoshi Hamauchi, Takahiro Tsushima, Nozomu Machida, Kentaro Yamazaki, Hirofumi Yasui, Hideyuki Harada, Tetsuo Nishimura, Yoko Nakasu

ANNALS OF ONCOLOGY 26 99-99 2015年11月
レゴラフェニブの早期効果予測は可能か?静岡がん・愛知がん共同観察研究[2]

小森梓, 谷口浩也, 濱内諭, 舛石俊樹, 木藤陽介, 長谷川裕子, 成田有季哉, 門脇重憲, 宇良敬, 安藤正志 …

日本癌治療学会誌 50(3) 2450-2450 2015年9月
大腸大腸がん分子標的薬の最新情報レゴラフェニブとTAS-102はどちらを先行すべきか? 静岡がん・愛知がん共同観察研究[3]

舛石俊樹, 谷口浩也, 濱内諭, 小森梓, 木藤陽介, 三谷誠一郎, 長谷川裕子, 成田有季哉, 門脇重憲, 宇良敬 …

日本癌治療学会誌 50(3) 1306-1306 2015年9月

もっとみる